36
📖 Lesson

Basic Neurochemistry-VII

PSYP610 - Neurological Bases of Behavior

🎯 Objectives

To familiarize the students with the:

  • Various NT and their role in the modulation of behaviors 🧠
  • Classification of Neurotransmitters πŸ“Š: Monoamines: Catecholamines πŸ§ͺ and Indoleamine πŸ’œ, acetylcholine 🎯, amino acid 🧬, and Peptide πŸ”—
  • Neurotransmitter's role in modulation of behaviors and Aberration ⚠️
  • Drugs and Behavior πŸ’ŠπŸŽ­
  • Classification of Psychopharmacological substances πŸ”¬
  • Behavioral correlates, Treatment 🩺
  • Mechanism of synaptic transmission πŸ“‘

🎯 Major Neurotransmitter: Acetylcholine (continued)

🎭 ACH and Behaviors

As we have discussed in the last lesson, Ach has a unique and important neurotransmitter role in the brain 🧠. Without the normal levels of Ach and its receptors working effectively the brain would not be able to command the muscles of the body πŸ’ͺ.

1️⃣ ⚑ Arousal

Ach has an important role as excitant of neural activity ⚑. This means that brain electrical activity is aroused and can be monitored by the Electroencephalographic (EEG) recordings πŸ“Š. When ACH is injected intravenously πŸ’‰ or applied to cortex 🧠 it leads to increased EEG activity ⬆️. Further, when anticholinergics are administered as they block and reduce Ach levels in the brain β¬‡οΈπŸ›‘, the EEG arousal is also blocked ⬇️. Interestingly, this does not affect the behavioral arousal πŸšΆβœ…).

Ach is involved in sleeping and awakening via the locus coeruleus 🧠, which may explain the involvement of Ach in brain electrical activity arousal ⚑.

2️⃣ πŸ’§ Drinking

Ach is important in drinking and fluid regulation πŸ’§. The regulation of the water intake takes place via the Ach mechanism 🎯. The cellular dehydration is mediated by the cholinoceptive system of neurons in the preoptic area of the hypothalamus πŸ₯. They monitor the extracellular space for volumetric changes (changes in the volume of fluid) πŸ“Š produced after changes in isotonic body fluids.

(Whenever the intracellular membrane runs short of fluid πŸ’§β¬‡οΈ it takes in fluids from the extracellular membrane, as the survival of cell is more important! 🧬) This leads to the release of Renin πŸ’‰ from kidneys which lead to increased formation of Angiotensin πŸ§ͺ which then stimulates the neurons in the preoptic area ⚑. Thus, this communication goes from the brain to the kidneys and back πŸ§ β†”οΈπŸ©Ί leading to an increase in fluid and salt intake β¬†οΈπŸ’§πŸ§‚. The messages begin with the Cholinoceptive receptors sending out the signals πŸ“‘.

3️⃣ 😾 Sham Rage and Attack

Sham rage 😾 is the physical appearance of rage without an object of rage in front of the animal (cats and rats πŸ±πŸ€). In cats rage appears in hissing and spitting 😾, and raised hair on the dorsal surface of the body and the tail 🦁. Sham rage is induced in cats and rats by the cholinergic stimulation of amygdala πŸ’š and septum 🧠.

Aggression is also produced by midbrain ventral tegmental area 🧠. Further, the killing attack pathways in rat πŸ€ (of mice 🐭) and cat 🐱 (of rats πŸ€) are cholinergically organized 🎯. The cholinergic stimulation of amygdala, LH, midbrain tegmental regions lead to a quiet biting attack in rat and cats 😼🦷. How do we know? ❓ This attack is blocked by atropine πŸ’ŠπŸ›‘.

4️⃣ πŸ›‘ Punishment

Reinforcing stimuli increases the probability of a response to it πŸŽβ¬†οΈ whereas punishing stimuli decreases the probability of a response to it πŸ›‘β¬‡οΈ. The intracranial self-stimulation is part of the reward systems and reinforcing so an animal would keep self-stimulating for its own reward πŸ”˜βš‘. On the other hand, the periventricular area in hypothalamus part of punishment systems 🚫. The ventromedial hypothalamus is part of this punishment system πŸ₯.

πŸ”¬ Experimental Setup

Rats previously trained for Variable Interval Schedule (VIS) πŸ“… for food are run in an experiment where every response is followed by a shock ⚑. (Remember VIS is when the time between reinforcement varies! ⏰) When every response is followed by a shock ⚑, a reduction in VIS response follows ⬇️.

πŸ§ͺ Lesion Effects

If we lesion the Ventromedial nuclei (VMN) 🧠, it leads to increase in the response which had been depressed (leads to disinhibition) ⬆️. Anti Ach also does the same πŸ’Š, which is they lead to an increase in disinhibition of the punished response ⬆️.

Inhibition of punished response means the animal would stop responding πŸ›‘, but disinhibition means that the response would return as the inhibitor has been blocked πŸ”„. AntiAch are involved in removing the inhibition πŸš«πŸ›‘.

5️⃣ 🧠 Alzheimer

Alzheimer's 🧠 is a disease of old age where degeneration of brain takes place to a point where the person cannot carry out any function πŸ‘΅πŸ‘΄. The important feature of this disease is loss of memory πŸ“šβŒ.

Recently muscarinic receptor agonists πŸ’Š have been used in the treatment of Alzheimer's disease. This replaces depleted Ach in the basal forebrain 🧠 as the neurons in this area degenerate ⬇️.

πŸ’Š Treatment Approaches

Another treatment of Alzheimer's patients is administration of acetylcholinesterase inhibitors πŸ’Š this increases levels of ACH in the synapse as the breakdown is blocked πŸ›‘), thereby increasing cholinergic activity in damaged brain areas β¬†οΈπŸ§ .

Physostigmine πŸ’Š was used earlier but results indicated strong side effects ⚠️.

Tetrahydroaminoacridine (THA, or tacrine) πŸ’Š, first cholinesterase inhibitor which has been approved for Alzheimer's patients βœ…. Patients given THA shown some reductions of Alzheimer's symptoms were able to resume normal activity 🚢. However, not all patients can use it as it has strong side effects on increasing liver enzymes ⚠️🩺.

πŸ”— Other Involvements

Ach is also involved in:

  • Learning πŸ“š
  • Memory 🧠
  • Motor behaviors πŸ’ͺ (it works in balance with DA for Parkinson's and other motor disorders βš–οΈ)
  • In pain ⚠️, in coordination with brain opioids πŸ’Š

🧬 Other NT's

In addition to the neurotransmitters, we have discussed so far, the Catecholamines πŸ§ͺ, the Indolamine πŸ’œ, and Acetylcholine 🎯; there are other neurotransmitters which are active within the CNS 🧠. We will discuss them in brief πŸ“‹.

1️⃣ ⚑ Glutamic Acid

Glutamate ⚑ and GABA are found in simple organisms 🦠. The first neurotransmitter to be evolved in the brain is Glutamate 🧬. Glutamate is an excitatory neurotransmitter ⚑, its receptors found all over the brain 🧠. Chinese food 🍜 contains a large amount of Monosodium Glutamate πŸ§‚.

There are three types of receptors: NMDA πŸ”΅, quisquilate 🟒 and the kainite receptors 🟣. The receptors are all important in working with other NTs πŸ”—.

2️⃣ πŸ›‘ GABA

Gamma Amino butyric acid (GABA) πŸ›‘ was first synthesized in 1883 known to be a metabolite of plant and microbial metabolism 🌱. It was discovered in the mammalian brain in the 1950's πŸ“…, and in very high concentrations in the brain and the spinal cord 🧠🦴. In the brain GABA is found in amounts 10-15 times greater than DA, NE or 5HT πŸ“ˆ also a minuscule amount found in the retina πŸ‘οΈ. Even till now it is not very extensively studied πŸ”.

It is generally classified as an inhibitory NT πŸ›‘ and accounts along with other amino acids for a major part of the neuronal transmission πŸ“‘. GABA works to balance the monoamines DA, NA and 5HT wherever they are involved βš–οΈ.

🩺 Clinical Involvement

GABA is implicated:

  • Directly in Huntington's chorea πŸ’ƒ which is due to degeneration of GABAminergic neurons πŸ§ β¬‡οΈ
  • Indirectly involved in Parkinson's 🀝
  • Epilepsy ⚑ (abnormality in the biochemistry of GABAminergic neurons 🧠)
  • Schizophrenia 🧠

βš—οΈ GABA Synthesis

This involves only two steps: one to synthesize it and one to break it down:

1️⃣ One Step Synthesis

One step synthesis from its amino acid precursor Glutamic Acid 🧬 which is decarboxylase by the enzyme Glutamic acid decarboxylase (GAD) βš—οΈ and coenzyme pyroxidal phosphate πŸ§ͺ, this process can be blocked by ions such as chloride and zinc πŸ›‘.

Glutamic acid β†’ GABA ✨

2️⃣ Catabolism

GABAβ€”is trans-aminated by GABA-A-oxoglutarate transaminase βš—οΈ. GABA is transformed into Succinic Acid Semialdehyde πŸ§ͺ to return back into the Krebs cycle πŸ”„.

In the transaminase process πŸ”„- GABA conversion is reversed to Glutamic acid through alpha ketoglutarate which acts as amine acceptor 🧬.

πŸ—ΊοΈ Distribution and Pharmacological Agents

From monkey to human brain 1968-1971 studies πŸ“… showed the highest GABAminergic concentrations πŸ“Š in:

  • The Substantia Nigra (SN) πŸ–€
  • Globus Pallidus (GP) 🧠
  • The Hypothalamus (hyp) πŸ₯
⚑ Agonists

The post receptor GABA agonist is muscimol πŸ’Š. This leads to increased arousal ⚑, self-mutilation 😰, increased feeding if placed in the hypothalamus (disinhibition of inhibition) πŸ½οΈβ¬†οΈ.

πŸ›‘ Antagonists

Post receptor antagonist or receptor blockade by picrotoxin πŸ’Š and bicuculine πŸ’Š πŸ›‘.

πŸ’Š Benzodiazepines

Benzodiazepines πŸ’Š (Valium and Librium) stimulate a particular site of GABAminergic neurons ⚑. This alleviates the anxiety symptoms/response πŸ˜°βœ….

3️⃣ πŸ”„ Glycine

Glycine πŸ”„ is another Inhibitory neurotransmitter like GABA πŸ›‘ however research is still ongoing to identify its role πŸ”. It is found in the mammalian spinal cord and the brain 🧠🦴. It is found in greater amounts in the spinal grey matter than the brain πŸ“Š. Suggesting it may be working with the interneuron πŸ”—. However, no distinct and clear glycine pathways in the brain ❓.

Strychnine πŸ’€ (poison) blocks the action of glycine πŸ›‘ and also blocks postsynaptic inhibition 🚫.

4️⃣ πŸ”— PEPTIDES

Neuroactive peptides πŸ”— are candidates for neurotransmitters πŸ§ͺ. Some of these are like orthodox NT's, some are performing modulatory or regulatory roles πŸŽ›οΈ, and that these also act as neurohormones πŸ’‰.

Include: BRAIN OPIOIDS 😌, ANGIOTENSIN II πŸ’§ (thirst), Oxytocin and Vasopressin ❀️, Luteinizing Hormone Releasing Hormones (LH-RH) 🧬, Substance P ⚠️ and Adreno-Corticotropic Hormone (ACTH) πŸ’‰.

😌 Brain Opioids

Endorphins 😌 (large molecules 🧬) and Enkephalins πŸ’Š (smaller molecules πŸ§ͺ):

Hughes and Kosterlitz (1975) πŸ‘¨β€πŸ”¬ in Aberdeen discovered the existence of brain opioids in the brain 🧠. This was a landmark finding ⭐ because for the first time it was found that this chemical compound was similar in composition to the opiate's morphine, heroin etc πŸ’‰.

In later researches, Huda Akil πŸ‘©β€πŸ”¬ and her research group reported that the highest concentration in Substantia Nigra πŸ–€, lateral hypothalamus πŸ₯, cerebral Cortex 🧠, Periaqueductal gray 🧠.

πŸ§ͺ Effects of Brain Opioids

Extracts taken out from the brain 🧠, when administered to laboratory animals led to:

  • Analgesia ⚠️❌
  • Wet dog shakes upon application πŸ• (in a manner similar to administration of opiates)
  • Akinesia πŸ›‘
  • Hypothermia πŸ₯Ά
  • Rigidity πŸ’ͺ
  • Catalepsy 🧊
❓ Natural Neuroleptics?

The question is whether brain opioids are natural neuroleptics or not (neuroleptics are antipsychotic drugs) πŸ’Š? πŸ€”

In some cases, psychotic patients who are not responding to other treatment drugs (neuroleptics) 🩺 have responded short term endorphin treatment πŸ˜Œβœ… (Mcgreer and Mcgreer 1980) πŸ“….

🎭 Behavioral Involvement

These are also involved in:

  • Emotions 😊😒
  • Growth πŸ“ˆ
  • Pleasure πŸ˜„ (acting through the mesolimbic DA pathways 🧠)
  • Stress induced analgesia ⚠️ (Akil et al 1975) πŸ“…
  • Growth and development πŸ‘Ά (Najam and Panksepp 1980) πŸ“…
🩺 Clinical Applications

Opioid antagonists πŸ’Š have also been found effective in treatment of autism and childhood disorder πŸ‘Ά. Panksepp et al's theory πŸ‘¨β€πŸ”¬ of brain opioids and attachment states that brain opiates are natural comforters in the brain 😌, it is when they are blocked that the addicts turn to morphine/heroin πŸ’‰, and autistic children have higher than normal brain opiate level therefore ⬆️.

The discovery that pain and acupuncture pathways πŸ“ are similar to brain opioids pathways in the body and spinal cord 🦴 provide strong evidence for the involvement of brain opiates in the pain and acupuncture ⚠️.

πŸ’‰ Narcotic Analgesics

Narcotic analgesics such as morphine πŸ’‰ heroin πŸ’‰ are:

  • Severely addictive πŸ”— and have a high tolerance value ⚠️
  • Potent analgesics ⚠️❌
  • Potent anti congestion 🫁
  • For stomach and digestive problems 🩺

The interesting aspect of opiates effect on pain is that it is only the affective component which is reduced 😌 (one does not feel the pain) ❀️❌ the physical component is still there βš οΈβœ…. Pain is still there but the patients do not care about it, the reaction to pain is diminished πŸ”„.

πŸŒ€ Psychotogenic Compounds

πŸŒ€ Hallucinogens

1️⃣ LSD

LSD πŸŒ€ is a potent drug in fact so potent that a small dose of 1/10,000 gram is effective ⚑. This has great tolerance to the point that the same dose is not effective if taken 2nd time which means an increased dosage needed every time for an effect to take place ⬆️. The LSD "trip" depends on the mood and personality of the user and can be controlled 🎭.

2️⃣ Mescaline

Mescaline 🌡 also hallucinogenic compound made from plants extracts in Mexico πŸ‡²πŸ‡½. It is used in religious ceremonies by tribes in Mexico πŸ™.

πŸ’Š Psychopharmacology

This area of specialization is the study of the effects of drugs on psychological processes πŸ§ πŸ’Š. It is both a basic and an applied science πŸ”¬. "A recognition of the interrelationships between pharmacological agents πŸ’Š, neuro regulators πŸ§ͺ, and behavior 🎭 has become essential for those involved in helping individuals who have psychiatric disorders 🩺" Therefore in order to develop drugs research in the laboratory is needed before the drugs can be tested and used- especially on humans πŸ‘¨β€πŸ”¬.

πŸ“Š Evidence Requirements

The evidence is provided when:

  • The symptoms of a psychiatric disorder are removed linked to neurotransmitter βœ…πŸ§ͺ, and then the normalization of behavior should occur with normalization of levels of NT in the brain πŸ§ βš–οΈ
  • Further, known effective exogenous substances should have similar chemical effects as the endogenous (brain) chemicals πŸ”„
  • Pharmacological substances should be able to interact with NTs at a given sites if they have the same chemical composition πŸ§¬πŸ”—

πŸ“š References

  • Kalat, J.W. (1998). Biological Psychology. Brooks/ Cole Publishing
  • Carlson, N. R. (2005). Foundations of physiological psychology. Pearson Education New Zealand.
  • Pinel, J. P. (2003). Biopsychology. (5th ed). Allyn & Bacon Singapore.
  • Bloom, F., Nelson., & Lazerson. (2001), Behavioral Neuroscience: Brain, Mind and Behaviors. (3rd ed). Worth Publishers New York
  • Bridgeman, B. (1988). The Biology of Behavior and Mind. John Wiley & Sons, New York
  • Seigel, G. J., Agranoff, B.W, Albers W.R. & Molinoff, P.B. (1989). Basic Neurochemistry: Molecular, Cellular and Medical Aspects
  • Cooper, J.R., F.E Bloom, F. E., & Roth, R. H. (1970). The Biochemical basis of neuropharmacology (5th Ed.). New York, Oxford Univ. Press.